| Literature DB >> 34356963 |
Amir Mari1,2, Tawfik Khoury2,3, Wisam Sbeit2,3.
Abstract
Background andEntities:
Keywords: CRC; adenomas; colonoscopy; diverticulitis
Mesh:
Year: 2021 PMID: 34356963 PMCID: PMC8305485 DOI: 10.3390/medicina57070682
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Demonstrate the flow chart of the study cohort.
Demographics, baseline characteristics, and colonoscopic findings.
| Parameter | Group A (with Diverticulitis) | Group B (Diverticulosis) | |
|---|---|---|---|
| Number of patients | 134 | 233 | - |
| Age | 68.3 ± 10.5 | 70.5 ± 7.8 | 0.01 |
| Gender, N (%) | |||
| Male | 93 (69.4) | 149 (63.9) | 0.28 |
| Female | 41 (30.6) | 84 (36.1) | |
| Medical history | |||
| Hyperlipidemia | 80 (59.7) | 136 (58.4) | 0.80 |
| Hypertension | 97 (72.4) | 161 (69.5) | 0.51 |
| Chornic renal failure | 5 (3.7) | 16 (6.9) | 0.21 |
| Congestive heart failure | 5 (3.7) | 15 (6.4) | 0.27 |
| Diabetes mellitus | 106 (79.1) | 45 (19.3) | <0.0001 |
| Obesity | 106 (79.1) | 43 (18.5) | <0.0001 |
| Smoking, N (%) | 43 (31.8) | 50 (21.5) | 0.02 |
| Statin use, N (%) | 62 (46.3) | 97 (41.6) | 0.38 |
| NSAID use, N (%) | 13 (9.7) | 19 (8.2) | 0.61 |
| Aspirin use, N (%) | 81 (60) | 127 (54.5) | 0.27 |
| Colonoscopic findings, N (%) | |||
| Adenomas and CRC | 44 (32.8) | 57 (24.5) | 0.08 |
| CRC alone | 2 (1.5) | 4 (1.7) | 0.87 |
| Adenomas alone | 42 (31.3) | 53 (22.7) | 0.07 |
| Adenoma detection rate, N (%) | 42 (31.3) | 53 (22.7) | - |
NSAID: non-steroidal anti-inflammatory drug; CRC: colorectal carcinoma.
Univariate analysis of colonoscopic findings association with diverticulitis.
| Pathological Findings | Odds Ratio | 95% CI | |
|---|---|---|---|
| Adenomas and CRC | 1.51 | 0.94–2.41 | 0.085 |
| Adenomas alone | 1.60 | 0.96–2.50 | 0.07 |
| CRC alone | 0.87 | 0.16–4.80 | 0.87 |
CRC: colorectal carcinoma.
Demographics and baseline characteristics of patients who had acute diverticulitis.
| Parameter | Group C | Group D | |
|---|---|---|---|
| Number of patients | 44 | 90 | |
| Age | 69.02 ± 9.5 | 67.9 ± 10.9 | 0.27 |
| Gender, N (%) | |||
| Male | 38 (86.4) | 55 (61.1) | 0.001 for male |
| Female | 6 (13.6) | 35 (38.9) | |
| Medical history | |||
| Hyperlipidemia | 24 (54.5) | 56 (62.2) | 0.19 |
| Hypertension | 31 (70.5) | 66 (73.3) | 0.36 |
| Chornic renal failure | 2 (4.5) | 3 (3.3) | 0.36 |
| Congestive heart failure | 3 (6.8) | 2 (2.2) | 0.09 |
| Diabetes mellitus | 34 (77.3) | 72 (80) | 0.35 |
| Obesity | 34 (77.3) | 72 (80) | 0.35 |
| Smoking, N (%) | 40 (90.5) | 3 (3.4) | <0.0001 |
| Statin use, N (%) | 21 (47.7) | 41 (45.6) | 0.40 |
| NSAID use, N (%) | 6 (13.6) | 7 (7.8) | 0.14 |
| Aspirin use, N (%) | 28 (63.6) | 53 (58.9) | 0.30 |
NSAID: non-steroidal anti-inflammatory drug.